Galera Therapeutics OTC Stock Forecast - Naive Prediction
| GRTX Stock | USD 0.02 0.0001 0.42% |
Galera OTC Stock outlook is based on your current time horizon.
At this time, the value of RSI of Galera Therapeutics' share price is approaching 49. This usually indicates that the otc stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Galera Therapeutics, making its price go up or down. Momentum 49
Impartial
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Galera Therapeutics based on different types of headlines from major news networks to social media. Using Galera Therapeutics hype-based prediction, you can estimate the value of Galera Therapeutics from the perspective of Galera Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Galera Therapeutics on the next trading day is expected to be 0.02 with a mean absolute deviation of 0 and the sum of the absolute errors of 0.07. Galera Therapeutics after-hype prediction price | USD 0.02 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Galera |
Galera Therapeutics Additional Predictive Modules
Most predictive techniques to examine Galera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Galera using various technical indicators. When you analyze Galera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Galera Therapeutics Naive Prediction Price Forecast For the 26th of January
Given 90 days horizon, the Naive Prediction forecasted value of Galera Therapeutics on the next trading day is expected to be 0.02 with a mean absolute deviation of 0, mean absolute percentage error of 0.00000182, and the sum of the absolute errors of 0.07.Please note that although there have been many attempts to predict Galera OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Galera Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Galera Therapeutics OTC Stock Forecast Pattern
| Backtest Galera Therapeutics | Galera Therapeutics Price Prediction | Buy or Sell Advice |
Galera Therapeutics Forecasted Value
In the context of forecasting Galera Therapeutics' OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Galera Therapeutics' downside and upside margins for the forecasting period are 0.0002 and 6.71, respectively. We have considered Galera Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Galera Therapeutics otc stock data series using in forecasting. Note that when a statistical model is used to represent Galera Therapeutics otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 104.8938 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0011 |
| MAPE | Mean absolute percentage error | 0.0486 |
| SAE | Sum of the absolute errors | 0.0691 |
Predictive Modules for Galera Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Galera Therapeutics. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Galera Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Galera Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Galera Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Galera Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Galera Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Galera Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Galera Therapeutics' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Galera Therapeutics' historical news coverage. Galera Therapeutics' after-hype downside and upside margins for the prediction period are 0.00 and 6.71, respectively. We have considered Galera Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Galera Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Galera Therapeutics is based on 3 months time horizon.
Galera Therapeutics OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Galera Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Galera Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Galera Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 6.69 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.02 | 0.02 | 15.61 |
|
Galera Therapeutics Hype Timeline
Galera Therapeutics is currently traded for 0.02. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Galera is anticipated to decline in value after the next headline, with the price expected to drop to 0.02. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -15.61%, whereas the daily expected return is currently at 0.0%. The volatility of related hype on Galera Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.02. About 36.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.91. Galera Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in a few days. Check out Historical Fundamental Analysis of Galera Therapeutics to cross-verify your projections.Galera Therapeutics Related Hype Analysis
Having access to credible news sources related to Galera Therapeutics' direct competition is more important than ever and may enhance your ability to predict Galera Therapeutics' future price movements. Getting to know how Galera Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Galera Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HESG | Health Sciences Gr | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MDGEF | Medigene AG | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AGTX | Agentix Corp | 0.00 | 0 per month | 3.84 | 0.01 | 1.65 | (5.62) | 49.60 | |
| STMM | Stemcell Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NBCO | Neon Bloom | 0.00 | 0 per month | 0.00 | (0.03) | 5.48 | (5.19) | 40.26 | |
| VCNX | Vaccinex | 0.00 | 0 per month | 11.98 | 0.14 | 32.35 | (25.37) | 101.27 | |
| ANTCF | Aion Therapeutic | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EMBT | Ember Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HEMP | Hemp Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IONM | Assure Holdings Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Galera Therapeutics
For every potential investor in Galera, whether a beginner or expert, Galera Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Galera OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Galera. Basic forecasting techniques help filter out the noise by identifying Galera Therapeutics' price trends.Galera Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Galera Therapeutics otc stock to make a market-neutral strategy. Peer analysis of Galera Therapeutics could also be used in its relative valuation, which is a method of valuing Galera Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Galera Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Galera Therapeutics otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Galera Therapeutics shares will generate the highest return on investment. By undertsting and applying Galera Therapeutics otc stock market strength indicators, traders can identify Galera Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0633 | |||
| Daily Balance Of Power | (0.07) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0229 | |||
| Day Typical Price | 0.0232 | |||
| Market Facilitation Index | 0.0015 | |||
| Price Action Indicator | 7.0E-4 | |||
| Period Momentum Indicator | (0.0001) | |||
| Relative Strength Index | 49.05 |
Galera Therapeutics Risk Indicators
The analysis of Galera Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Galera Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting galera otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.52 | |||
| Semi Deviation | 5.64 | |||
| Standard Deviation | 6.69 | |||
| Variance | 44.74 | |||
| Downside Variance | 40.9 | |||
| Semi Variance | 31.81 | |||
| Expected Short fall | (5.61) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Galera Therapeutics
The number of cover stories for Galera Therapeutics depends on current market conditions and Galera Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Galera Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Galera Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Galera Therapeutics Short Properties
Galera Therapeutics' future price predictability will typically decrease when Galera Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Galera Therapeutics often depends not only on the future outlook of the potential Galera Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Galera Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.5 M | |
| Cash And Short Term Investments | 18.3 M |
Additional Tools for Galera OTC Stock Analysis
When running Galera Therapeutics' price analysis, check to measure Galera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galera Therapeutics is operating at the current time. Most of Galera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Galera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galera Therapeutics' price. Additionally, you may evaluate how the addition of Galera Therapeutics to your portfolios can decrease your overall portfolio volatility.